Fluence, a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, is supporting the widespread expansion of...
Argentina has taken a bold step towards becoming a major player in the global cannabis market by creating a regulatory agency specifically designed...
Sales of cannabis for medicinal purposes in Portugal are still not very expressive, but show signs of growth, according to data revealed yesterday by...
By the end of June 2022, Infarmed — National Authority for Medicines and Health Products IP granted 61 licenses and 172 pre-licenses to companies...
Infarmed — Autoridade Nacional do Medicamento e Produtos de Saúde IP published an analysis of the activities carried out in the medical cannabis sector in Portugal in the last...
The Australian medicines regulator, the Therapeutic Goods Administration (TGA), has issued 73 infringement notices about claims by medical cannabis companies in their...
The President of the Ordem dos Farmacêuticos, Hélder Mota Filipe, said today that it is crucial to make “a very clear distinction between medical cannabis and recreational cannabis”, because...
Fátima Godinho Carvalho, executive director of LEF – Laboratory of Pharmaceutical Studies since 2018, states that “from an analytical point of view, cannabis is a matrix...
Since the beginning of August, Switzerland has joined the European countries that already allow the use of cannabis for medicinal purposes through prescription...
A survey carried out by the American company “The Harris Poll”, on behalf of Curaleaf Holdings, reveals that 91% of adults aged 21 and over who have used...